Toronto - Delayed Quote CAD
Knight Therapeutics Inc. (GUD.TO)
6.00
-0.02
(-0.33%)
At close: June 6 at 4:00:01 PM EDT
Research Analysis
Earnings Estimate
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 0.02 | 0.03 | 0.14 | 0.06 |
| Low Estimate | 0.02 | 0.03 | 0.14 | 0.06 |
| High Estimate | 0.02 | 0.03 | 0.14 | 0.06 |
| Year Ago EPS | -0.02 | -- | 0.04 | 0.14 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | 94.99M | 108.54M | 401.56M | 444.04M |
| Low Estimate | 92M | 105.6M | 394.3M | 422.1M |
| High Estimate | 103.01M | 111M | 406.2M | 462.9M |
| Year Ago Sales | 95.57M | 92.26M | 371.3M | 401.56M |
| Sales Growth (year/est) | -0.61% | 17.64% | 8.15% | 10.58% |
Earnings History
| Currency in CAD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | 0.03 | 0.02 | 0.01 | -0.01 |
| EPS Actual | -0.02 | 0 | 0.11 | 0.02 |
| Difference | -0.05 | -0.02 | 0.1 | 0.03 |
| Surprise % | -160.33% | -100.00% | 1,000.00% | 300.00% |
EPS Trend
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0.02 | 0.03 | 0.14 | 0.06 |
| 7 Days Ago | 0.02 | 0.01 | 0.03 | 0.04 |
| 30 Days Ago | 0.02 | 0.01 | 0.03 | 0.04 |
| 60 Days Ago | 0.02 | 0 | 0.02 | 0.18 |
| 90 Days Ago | 0.02 | 0 | 0.02 | 0.18 |
EPS Revisions
| Currency in CAD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | 1 | -- | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | 1 | 1 |
| Down Last 30 Days | -- | -- | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| GUD.TO | 210.50% | -- | 211.80% | -57.14% |
| S&P 500 | 13.13% | 2.46% | 7.55% | 14.08% |
Upgrades & Downgrades
| Maintains | Raymond James: Outperform to Outperform | 3/6/2024 |
Related Tickers
BHC.TO Bausch Health Companies Inc.
6.53
+3.00%
CPH.TO Cipher Pharmaceuticals Inc.
13.25
+8.08%
HLS.TO HLS Therapeutics Inc.
4.9200
-0.40%
CTX.TO Crescita Therapeutics Inc.
0.4700
-12.96%
ROMJ.V Rubicon Organics Inc.
0.4250
-3.41%
HASH.V SIMPLY SOLVENTLESS CONCENTRATES
0.1850
0.00%
MDP.TO Medexus Pharmaceuticals Inc.
2.8400
-2.07%
CRON.TO Cronos Group Inc.
2.7200
+4.21%
CRDL.TO Cardiol Therapeutics Inc.
1.9200
+2.67%
RX.V BioSyent Inc.
11.95
+2.14%